| Active Market | Forge Price1 | Last Funding Round | Trade Eligibility | ||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Company | Sector & Subsector | Market Activity4   |
Highest Bid | Lowest Ask | Last Matched | +/- to LFR | $ Total Bids |
$ Total Asks |
# Bids |
# Asks |
Current Price |
6-month |
1-year |
Total Funding |
Round | Date | Amount Raised |
Post-Money Valuation3 |
Price |
Key Investors | Common | Preferred | Fund | ||
 | AIRNA | Healthcare Medical Devices | Limited | $xx.xx | $xx.xx | $xx.xx | xx% | -- | -- | -- | -- | Not available | -- | -- | $245.25M | Series B | 4/1/2025 | $155M | $330.71M | $0.93 | Venrock, Forbion, RTW Investments, Nextech Invest, ARCH Venture Partners, ND Capital | ||||
 | Airware (pre-spinoff) | Industrial Industrial Software | Limited | $xx.xx | $xx.xx | $xx.xx | xx% | -- | -- | -- | -- | Not available | -- | -- | $101.13M | Series C1 | 5/26/2016 | $3M | $194.99M | -- | Danhua Capital and other undisclosed investors | ||||
 | Altitude Learning | Education Other Education | Limited | $xx.xx | $xx.xx | $xx.xx | xx% | -- | -- | -- | -- | Not available | -- | -- | $148.4M | Series C | 5/2/2017 | $40M | $401.65M | $2.72 | Undisclosed Investors | ||||
 | Anyvoice | Consumer & Lifestyle Other Consumer & Lifestyle | Limited | $xx.xx | $xx.xx | $xx.xx | xx% | -- | -- | -- | -- | Not available | -- | -- | $52.23M | Series A | 10/20/2025 | $41.54M | $294.73M | $1.50 | Undisclosed Investors | ||||
 | Armor | Enterprise Software Cybersecurity | Limited | $xx.xx | $xx.xx | $xx.xx | xx% | -- | -- | -- | -- | Not available | -- | -- | $178.3M | Series F | 4/5/2017 | $118.45M | $328.93M | $5.46 | Signapore Technologies Telemedia | ||||
 | Arthrosi Therapeutics | Healthcare Biotech & Pharma | Limited | $xx.xx | $xx.xx | $xx.xx | xx% | -- | -- | -- | -- | Not available | -- | -- | $294.54M | Series E | 10/8/2025 | $148.1M | $385.03M | $6.54 | Prime Eight Capital, CR Biotech, HighLight Capital, HM Venture Partners, ReliantTech | ||||
 | Attralus | Healthcare Biotech & Pharma | Limited | $xx.xx | $xx.xx | $xx.xx | xx% | -- | -- | -- | -- | Not available | -- | -- | $344M | Series B | 2/6/2024 | $172.6M | $428.81M | $7.76 | Logos Capital, Janus Henderson Investors, Redmile Group, Samsara BioCapital, Sarissa Capital Management, Surveyor Capital, Vivo Capital, venBio Partners, Alpha Wave Ventures, Bristol Myers Squibb | ||||
 | Belong Health | Missing Missing | Limited | $xx.xx | $xx.xx | $xx.xx | xx% | -- | -- | -- | -- | Not available | -- | -- | $102.15M | Series B | 6/13/2025 | $57M | $345.18M | $0.39 | Undisclosed Investors | ||||
 | BlackSwan Technologies | Enterprise Software Business Operations | Limited | $xx.xx | $xx.xx | $xx.xx | xx% | -- | -- | -- | -- | Not available | -- | -- | $262.91M | Series B | 12/2/2022 | $79.35M | $472.32M | $79.14 | Undisclosed Investors | ||||
 | Bluefish | Enterprise Software Productivity | Limited | $xx.xx | $xx.xx | $xx.xx | xx% | -- | -- | -- | -- | Not available | -- | -- | $67M | Series B-2 | 4/18/2026 | $13M | $343.04M | $11.37 | Threshold Ventures, New Enterprise Associates, Amex Ventures, TIAA Ventures, Salesforce Ventures, Bloomberg Beta, Crane Venture Partners, Laconia, Swift Ventures | ||||
 | Bungalow | Consumer & Lifestyle Travel & Hospitality | Limited | $xx.xx | $xx.xx | $xx.xx | xx% | -- | -- | -- | -- | Not available | -- | -- | $40.55M | Series 1C | 7/23/2025 | $14.99M | $79.52M | $0.05 | Undisclosed Investors | ||||
 | Caffeine | Consumer & Lifestyle Entertainment | Limited | $xx.xx | $xx.xx | $xx.xx | xx% | -- | -- | -- | -- | Not available | -- | -- | $570.04M | Series AA | 12/20/2023 | $10M | $65.85M | $0.96 | Undisclosed Investors | ||||
 | cAMPfield Therapeutics | Healthcare Other Healthcare | Limited | $xx.xx | $xx.xx | $xx.xx | xx% | -- | -- | -- | -- | Not available | -- | -- | $180M | Series A | 6/18/2026 | $177.98M | $297.85M | $5.22 | Frazier Life Sciences, Deep Track Capital, Forbion, Abingworth, Venrock, Longitude Capital, Novo Holdings, RA Capital | ||||
 | Cantex Pharmaceuticals | Healthcare Biotech & Pharma | Limited | $xx.xx | $xx.xx | $xx.xx | xx% | -- | -- | -- | -- | Not available | -- | -- | $67.87M | Series D | 11/24/2014 | $34.31M | $276.31M | $0.96 | Undisclosed Investors | ||||
 | Capella Space | Industrial Aerospace & Defense | Limited | $xx.xx | $xx.xx | $xx.xx | xx% | -- | -- | -- | -- | Not available | -- | -- | $348.19M | Series C-4 | 2/7/2025 | $100M | $437.93M | $2.29 | Undisclosed Investors | ||||
 | Censys | Enterprise Software Cybersecurity | Limited | $xx.xx | $xx.xx | $xx.xx | xx% | -- | -- | -- | -- | Not available | -- | -- | $146.72M | Series D | 3/31/2026 | $40M | $442.95M | $3.34 | Morgan Stanley, Decibel Partners, Greylock, GV, Intel Capital, LDV Partners | ||||
 | Chartboost | Enterprise Software Sales & Marketing / Adtech | Limited | $xx.xx | $xx.xx | $xx.xx | xx% | -- | -- | -- | -- | Not available | -- | -- | $22.45M | Series B | 1/8/2013 | $20.08M | $122M | $1.26 | Sequoia Capital, TransLink Capital, Finaventures, SharesPost, SK Telecom Americas | ||||
 | Checkerspot | Industrial Materials | Limited | $xx.xx | $xx.xx | $xx.xx | xx% | -- | -- | -- | -- | Not available | -- | -- | $167.28M | Series D | 7/27/2026 | $25.06M | $102.68M | $0.27 | Undisclosed Investors | ||||
 | Chroma Medicine | Healthcare Biotech & Pharma | Limited | $xx.xx | $xx.xx | $xx.xx | xx% | -- | -- | -- | -- | Not available | -- | -- | $262M | Series B | 3/1/2023 | $135M | $450.56M | $2.60 | ARCH Venture Partners, DCVC Bio, Mubadala Capital, Sixth Street, Alexandria Venture Investments, Atlas Venture, Casdin Vapital, Cormorant Asset Management, Janus Henderson Investors, Newpath Partners, Omega Funds, Osage University Partners, Sofinnova Partners, T Rowe Price, Wellington Management | ||||
 | Clarifai | Enterprise Software Data Intelligence | Limited | $xx.xx | $xx.xx | $xx.xx | xx% | -- | -- | -- | -- | Not available | -- | -- | $100.08M | Series C | 10/15/2021 | $58.44M | $426.19M | $16.15 | New Enterprise Associates, Menlo Ventures, Union Square Ventures, Lux Capital, LDV Capital, Corazon Capital, NYU Innovation Venture Fund, CPP Investments, NextEquity Partners, SineWave Ventures, Trousdale Capital | ||||
 | CloudX | Enterprise Software Productivity | Limited | $xx.xx | $xx.xx | $xx.xx | xx% | -- | -- | -- | -- | Not available | -- | -- | $45.2M | Series A-4 | 6/18/2026 | $15M | $339.88M | $16.12 | Undisclosed Investors | ||||
 | Codoxo | Healthcare Healthcare Software | Limited | $xx.xx | $xx.xx | $xx.xx | xx% | -- | -- | -- | -- | Not available | -- | -- | $75M | Series C | 12/17/2025 | $35M | $275.36M | $13.93 | CVS Health Ventures, Echo Health Ventures, Sands Capital Management, 111 West Capital, Brewer Lane Ventures, Wipro Ventures, 450 Ventures, QED Investors | ||||
 | Cogito | Enterprise Software Sales & Marketing / Adtech | Limited | $xx.xx | $xx.xx | $xx.xx | xx% | -- | -- | -- | -- | Not available | -- | -- | $194.37M | Series C-1 | 9/5/2019 | $25M | $267.34M | $5.01 | New York Life Ventures, Salesforce Ventures, Goldman Sachs | ||||
 | CognitiveScale | Enterprise Software Data Intelligence | Limited | $xx.xx | $xx.xx | $xx.xx | xx% | -- | -- | -- | -- | Not available | -- | -- | $51.81M | Series B-1 | 6/13/2017 | $8.29M | $239.36M | $6.85 | Norwest Venture Partners, Intel Capital, Microsoft Ventures, The Westly Group, USAA | ||||